Kymera Therapeutics to announce KT-621 BROADEN2 Phase 2b atopic dermatitis trial results on November 23, 2026
KYMR•Kymera Therapeutics said it will announce results from its KT-621 BROADEN2 Phase 2b atopic dermatitis trial on November 23, 2026.
1. Results announcement
Kymera Therapeutics said it will announce results from its KT-621 BROADEN2 Phase 2b atopic dermatitis trial on November 23, 2026.




